DexCom, Inc. (DXCM)
91.04
-1.30
(-1.41%)
USD |
NASDAQ |
Aug 24, 16:00
91.52
+0.48
(+0.53%)
After-Hours: 20:00
DexCom Price to Book Value : 13.11 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 13.29 |
| August 20, 2026 | 12.99 |
| August 19, 2026 | 12.94 |
| August 18, 2026 | 12.90 |
| August 17, 2026 | 12.78 |
| August 14, 2026 | 12.92 |
| August 13, 2026 | 13.17 |
| August 12, 2026 | 13.07 |
| August 11, 2026 | 12.89 |
| August 10, 2026 | 12.62 |
| August 07, 2026 | 12.20 |
| August 06, 2026 | 11.95 |
| August 05, 2026 | 11.90 |
| August 04, 2026 | 12.52 |
| August 03, 2026 | 12.57 |
| July 31, 2026 | 12.01 |
| July 30, 2026 | 10.73 |
| July 29, 2026 | 10.82 |
| July 28, 2026 | 10.78 |
| July 27, 2026 | 10.56 |
| July 24, 2026 | 10.30 |
| July 23, 2026 | 10.15 |
| July 22, 2026 | 10.28 |
| July 21, 2026 | 10.76 |
| July 20, 2026 | 10.90 |
| Date | Value |
|---|---|
| July 17, 2026 | 11.04 |
| July 16, 2026 | 11.23 |
| July 15, 2026 | 10.47 |
| July 14, 2026 | 10.67 |
| July 13, 2026 | 10.99 |
| July 10, 2026 | 10.79 |
| July 09, 2026 | 10.51 |
| July 08, 2026 | 10.66 |
| July 07, 2026 | 10.59 |
| July 06, 2026 | 10.42 |
| July 02, 2026 | 10.26 |
| July 01, 2026 | 9.914 |
| June 30, 2026 | 9.696 |
| June 29, 2026 | 9.133 |
| June 26, 2026 | 9.154 |
| June 25, 2026 | 8.959 |
| June 24, 2026 | 9.103 |
| June 23, 2026 | 8.995 |
| June 22, 2026 | 9.014 |
| June 18, 2026 | 9.458 |
| June 17, 2026 | 9.296 |
| June 16, 2026 | 9.548 |
| June 15, 2026 | 9.686 |
| June 12, 2026 | 9.836 |
| June 11, 2026 | 9.821 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Abbott Laboratories | 3.950 |
| Insulet Corp. | 7.101 |
| Baxter International, Inc. | 2.207 |
| Globus Medical, Inc. | 2.368 |
| Stryker Corp. | 5.242 |
Price to Book Value Related Metrics
| PE Ratio | 35.94 |
| PS Ratio | 7.283 |
| PEG Ratio | 0.4646 |
| Price to Free Cash Flow | 25.76 |
| Price | 91.04 |
| Earnings Yield | 2.78% |
| Market Cap | 34.36B |
| PEGY Ratio | 0.4646 |
| Operating PE Ratio | 31.77 |
| Normalized PE Ratio | 35.94 |